Globus MedicalMEX:GMED 92 FCF Margin % is 21.42% as of Mar. 2026, which is 26% above its 10-year median of 17.02. GuruFocus rates MEX:GMED with a GF Score™ of 92/100 and a GF Value™ of MXN1,675.11 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Globus Medical ranks better than 89.83% on this metric.
The historical rank and industry rank for Globus Medical's FCF Margin % or its related term are showing as below:
MEX:GMED'
s FCF Margin % Range Over the Past 10 Years
Min: 10.21 Med: 17.02 Max: 22.9
Current: 19.21
During the past 13 years, the highest FCF Margin % of Globus Medical was 22.90%. The lowest was 10.21%. And the median was 17.02%.
MEX:GMED's FCF Margin % is ranked better than 89.83% of 816
companies
in the Medical Devices & Instruments industry
Industry Median: -0.22
vs MEX:GMED: 19.21
Globus Medical FCF Margin % Related Terms
Globus Medical FCF Margin % Historical Data
* Premium members only.
The historical data trend for Globus Medical's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:GMED vs PODD, PEN, MASI: FCF Margin % Comparison
For the Medical Devices subindustry, Globus Medical's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Globus Medical FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Globus Medical's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Globus Medical's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Globus Medical (MEX:GMED) has a FCF Margin % of 21.42% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Globus Medical and its competitors. This is 26% above median its historical median of 17.02. Over the past decade, Globus Medical's FCF Margin % has ranged from 10.21 to 22.90. According to the industry distribution chart, Globus Medical ranks #83 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 10.2%.
Is Globus Medical's FCF Margin % too high?
Globus Medical's current FCF Margin % of 21.42% is 26% above median its 10-year median of 17.02. Over the past 10 years, this metric has ranged from a low of 10.21 to a high of 22.90. Based on the distribution chart, Globus Medical ranks #83 out of 816 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Globus Medical has a GF Score™ of 92/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Globus Medical's FCF Margin % compare to PODD and PEN?
According to the Medical Devices & Instruments industry distribution chart, Globus Medical ranks #83 out of 816 companies for FCF Margin %. This places Globus Medical in the top 10% of its industry — outperforming the majority of peers. Historically, Globus Medical's own FCF Margin % has ranged from 10.21 to 22.90 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Globus Medical and its competitors. Globus Medical's current FCF Margin % is 21.42%, which is 26% above median its own 10-year median of 17.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Globus Medical stock overvalued right now?
Based on GuruFocus' analysis, Globus Medical (MEX:GMED) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN1,675.11, compared to a current price of MXN1,465.00 — trading 12.5% below its estimated fair value. The current FCF Margin % is 21.42%, which is 26% above median its 10-year median of 17.02. Globus Medical's overall GF Score™ is 92/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Globus Medical (MEX:GMED), the current FCF Margin % is 21.42% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Globus Medical (MEX:GMED) Overvalued in 2026?
Based on GuruFocus' analysis, Globus Medical stock appears to be undervalued.
The current stock price of MXN1,465.00 is trading 12.5% below its estimated GF Value™ of MXN1,675.11.
GuruFocus considers Globus Medical to be Modestly Undervalued.
Key valuation signals for MEX:GMED:
FCF Margin %: 21.42% (26% above median its 10-year median of 17.02)
GF Value™: MXN1,675.11 vs. price of MXN1,465.00 (12.5% below fair value)
No single metric tells the full story. See the MEX:GMED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
92GF Score
Get the complete analysis for MEX:GMED
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:GMED has been successfully added to your 
